New therapies for ovarian cancer.
Schilder
R J
RJ
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Ozols
R F
RF
D000470:Alkaloids / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007274:Injections, Intraperitoneal; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel; D010641:Phenotype
D000470:Alkaloids; D009944:Organoplatinum Compounds; D005978:Glutathione; D017239:Paclitaxel; D002945:Cisplatin; C049777:ormaplatin